Share this NATF page   

September President's Letter


Labor Day heralds the unofficial end of summer.  At NATF, we’ve had our busiest and most productive summer ever.  We hired two new staff members, launched improvements in our website, held informational meetings about thrombosis in diverse communities, and put the finishing touches on our 8th Thrombosis Summit, to be held on Saturday morning, September 20, at the Fairmont Copley Plaza Hotel in Boston.

Click here to read the full letter.

Help prioritize educational topics of importance to patients & families for DVT/PE prevention!!

NATF has collaborated with the Patient Centered Outcomes Research Institute (PCORI), and the Johns Hopkins Medicine Institutional Review Board, to embark on an important project to build patient education for the prevention of venous thromboembolism (VTE). Scroll down to participate in this project!

DVT Stories

"My family experience with DVT/PE"


What is our story? I had a PE 15 years ago and a DVT a year later. The first question I am always asked is what were the symptoms. For the PE, I had no symptoms until I had shortness of breath and a rapid pulse for no apparent reason.

Read Rosemary's story.

'American Idol' finalist Michael Johns dead at 35

Michael Johns

(CNN) 4 August 2014 -- A one-time "American Idol" finalist has died, the show's official Facebook page announced.

"Michael Johns was an incredible talent and we are deeply saddened by the news of his passing," a joint statement from Fox, FremantleMedia North America and 19 Entertainment said.

Read the full article.

Thrombosis Education

2014 Thrombosis Summit Video

Dr. Goldhaber discusses NATF's upcoming Thrombosis Weekend, which will take place at the Fairmont Copley Plaza Hotel in Boston, September 19-20.

To register, visit:

New CMEducation program

Program 1 - Comprehensive Tm

Program Co-Chairs Samuel Z. Goldhaber, MD and Christian T. Ruff, MD, of Harvard Medical School, discuss the foundation role of oral Factor Xa and direct thrombin inhibitors stroke prevention in atrial firbrillation and acute treatment of VTE.

See more here.

Patient Advocacy Committee Update

Kathryn Mikkelsen, co-chair of the Patient Advocacy Committee, discusses a few of the committee's upcoming plans and initiatives.

Articles and Updates

Exercise May Shield Older Women From Afib

Older -black -woman -exercising







MedPage Today: 22 August 2014 - High-intensity exercise was tied to a reduced risk for atrial fibrillation in post-menopausal women and obese women in particular, researchers said.

Read the article here.

FDA approves use of Eliquis to treat leg, lung clots




Reuters: 21 August 2014 - Bristol-Myers Squibb Co and Pfizer Inc on Thursday said U.S. regulators have approved an expanded use for their Eliquis blood clot preventer, to treat blood clots in the legs and lungs.

The drugmakers said the U.S. Food and Drug Administration also approved use of the pill to reduce risk of recurrent blood clots in the deep veins of the leg, called deep vein thrombosis, and in the lung, called pulmonary embolism, following initial therapy.

Read the article here.

Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Quiz

Blue red veins

 20 August 2014 - Take the DVT/PE quiz to see what you know about thrombosis-related diseases.

Take the quiz here.

About NATF





Giving to NATF

North American Thrombosis Forum
368 Boylston Street
Brookline, MA 02445

617 - 730 - 4120

NATF is a 501(c) nonprofit

Contact Us

© 2012 North American Thrombosis Forum

Web Development by MTC